-
Alzheimers Res Ther · Jan 2013
Should interventions to treat or prevent Alzheimer's disease be tested in a population or as targeted treatment of highly selected study participants?
- Pierre Jean Ousset, Julien Delrieu, and Bruno Vellas.
- Alzheimer's Disease Clinical Research Centre, Gérontopôle, Toulouse University Hospital, 170 avenue de Casselardit, 31059, Toulouse cedex, France.
- Alzheimers Res Ther. 2013 Jan 1; 5 (6): 62.
AbstractSymptomatic treatments for Alzheimer's disease should retain a place in the advanced stages of disease since their actions on these symptoms, even if not modifying the course of disease, are critical for improving patients' comfort and reducing the burden felt by caregivers, especially those facing behavioral disorders. In mild or prodromal stages, the opportunity to act on specific pathophysiological targets should be considered. These targeted and tailored therapies have the greatest chance to be active in the early stages of disease, in the context of heterogeneous pathological mechanisms to be specified by reliable and accessible biomarkers. Finally, interventional approaches in large populations seem particularly appropriate for prevention strategies.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..